Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Golimumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years	Golimumab	Ulcerative colitis	Gastroenterology	2023	View \| Download
Govorestat for treating galactosemia in people aged 2-65 years	Govorestat (AT-007)	Galactosemia	Endocrine Nutritional and Metabolic Disorders	2024	View \| Download
Granexin Gel for Diabetic Foot Ulcers	Granexin (ACT-1)	Diabetic foot ulcer (DFU)	Cardiovascular System , Dermatology , Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Guadecitabine for Treatment of Naive Acute Myeloid Leukaemia	Guadecitabine (SGI-110)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2017	View \| Download
Guselkumab for active psoriatic arthritis	Guselkumab (Tremfya; CNTO-1959)	Psoriatic arthritis	Dermatology , Rheumatology	2019	View \| Download
Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years	Guselkumab (Tremfya; CNTO-1959)	Plaque psoriasis	Dermatology	2024	View \| Download
Guselkumab for treating moderately to severely active Crohn’s disease	Guselkumab (Tremfya; CNTO-1959)	Crohn's disease	Gastroenterology , Immunology	2022	View \| Download
Guselkumab for treating ulcerative colitis	Guselkumab (Tremfya; CNTO-1959)	Ulcerative colitis	Gastroenterology	2022	View \| Download
High dose aflibercept for treating neovascular age-related macular degeneration (nAMD)	Aflibercept	Age-related macular degeneration (AMD)	Ophthalmology	2022	View \| Download
High-dose aflibercept for diabetic macular oedema	Aflibercept	Diabetic macular oedema	Endocrine Nutritional and Metabolic Disorders , Ophthalmology	2022	View \| Download